MA44057A - Produit combiné - Google Patents

Produit combiné

Info

Publication number
MA44057A
MA44057A MA044057A MA44057A MA44057A MA 44057 A MA44057 A MA 44057A MA 044057 A MA044057 A MA 044057A MA 44057 A MA44057 A MA 44057A MA 44057 A MA44057 A MA 44057A
Authority
MA
Morocco
Prior art keywords
combined product
combined
product
Prior art date
Application number
MA044057A
Other languages
English (en)
Inventor
Giancarlo A Biagini
Gemma L Nixon
Paul M O'neill
Stephen A Ward
Original Assignee
Liverpool School Tropical Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liverpool School Tropical Medicine filed Critical Liverpool School Tropical Medicine
Publication of MA44057A publication Critical patent/MA44057A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA044057A 2015-12-16 2016-12-16 Produit combiné MA44057A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1522232.6A GB201522232D0 (en) 2015-12-16 2015-12-16 Combination product

Publications (1)

Publication Number Publication Date
MA44057A true MA44057A (fr) 2018-10-24

Family

ID=55274872

Family Applications (1)

Application Number Title Priority Date Filing Date
MA044057A MA44057A (fr) 2015-12-16 2016-12-16 Produit combiné

Country Status (6)

Country Link
US (1) US10799494B2 (fr)
EP (1) EP3389659A1 (fr)
CN (1) CN108697705A (fr)
GB (1) GB201522232D0 (fr)
MA (1) MA44057A (fr)
WO (1) WO2017103615A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018084809A1 (fr) * 2016-11-02 2018-05-11 Nanyang Technological University Méthodes permettant le traitement ou la prévention d'infections mycobactériennes
EP3681874B1 (fr) 2017-09-13 2022-04-06 Cerepeut, Inc. Composé à petites molécules
JP7659269B2 (ja) * 2018-12-21 2025-04-09 ユニバーシティ・オブ・ノートル・ダム・デュ・ラック 抗酸菌症治療のためのｂｄオキシダーゼ阻害剤の発見
CA3151712A1 (fr) * 2019-09-30 2021-04-08 Jerome Emile Georges Guillemont Inhibiteurs de cytochrome bd comme agents antibacteriens pour le traitement de la tuberculose
AU2020358643A1 (en) * 2019-09-30 2022-05-26 Janssen Sciences Ireland Unlimited Company 4-quinolinone antibacterial compounds
CA3163103A1 (fr) * 2019-11-26 2021-06-03 Nanyang Technological University Composes pour le traitement de la tuberculose
DK4069691T3 (da) 2019-12-06 2024-10-28 Vertex Pharma Substituerede tetrahydrofuraner som modulatorer af natriumkanaler
WO2022214520A1 (fr) 2021-04-07 2022-10-13 Janssen Sciences Ireland Unlimited Company Composés antibactériens
WO2022214519A1 (fr) 2021-04-07 2022-10-13 Janssen Sciences Ireland Unlimited Company Composés antibactériens
MA64853B1 (fr) 2021-06-04 2025-11-28 Vertex Pharmaceuticals Incorporated N-(hydroxyalkyl (hétéro)aryl) tétrahydrofuran carboxamides utilisés en tant que modulateurs de canaux sodiques
PT4426434T (pt) 2021-11-02 2025-11-24 Flare Therapeutics Inc Agonistas inversos de pparg e suas utilizações
JP2025513455A (ja) 2022-04-22 2025-04-24 バーテックス ファーマシューティカルズ インコーポレイテッド 疼痛の治療のためのヘテロアリール化合物
CN117883436B (zh) * 2023-11-29 2025-05-02 中国科学院深圳先进技术研究院 内过氧化合物单用或与呼吸链抑制剂联用在制备抗菌药物中的用途、抗菌药物
WO2025111889A1 (fr) * 2023-11-29 2025-06-05 中国科学院深圳先进技术研究院 Utilisation d'endoperoxyde seul ou en combinaison avec un inhibiteur de la chaîne respiratoire dans la préparation d'un médicament antibactérien, et médicament antibactérien et son utilisation dans le traitement de la tuberculose
CN118453579A (zh) * 2024-03-30 2024-08-09 中国科学院深圳先进技术研究院 抗结核分枝杆菌组合物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201020076D0 (en) 2010-11-26 2011-01-12 Liverpool School Tropical Medicine Antimalarial compounds

Also Published As

Publication number Publication date
US10799494B2 (en) 2020-10-13
CN108697705A (zh) 2018-10-23
EP3389659A1 (fr) 2018-10-24
GB201522232D0 (en) 2016-01-27
US20190151305A1 (en) 2019-05-23
WO2017103615A1 (fr) 2017-06-22

Similar Documents

Publication Publication Date Title
MA44057A (fr) Produit combiné
EP3292156C0 (fr) Produit cellulosique nanofibrillaire
EP3357488A4 (fr) Produit cosmétique
EP3338592A4 (fr) Produit cosmétique
EP3332763A4 (fr) Produit cosmétique
EP3460016A4 (fr) Produit stratifié
SI3356264T1 (sl) Postopek za razporejanje izdelkov
EP3456311A4 (fr) Produit cosmétique
EP3403642A4 (fr) Produit cosmétique
DK3508196T3 (da) Aripiprazol-prodrugsammensætninger
EP3449898A4 (fr) Produit cosmétique
EP3357686A4 (fr) Produit décoratif métallique
EP3509544A4 (fr) Produit orthétique
FR3044643B1 (fr) Produit alimentaire emballe
EP3527089A4 (fr) Produit de jambe
EP3482652A4 (fr) Produit cosmétique
DK3307076T3 (da) Podepartikelprodukt
PL3539401T3 (pl) Połączony wyrób tekstylny
EP3417249A4 (fr) Détecteur de produit
EP3320781A4 (fr) Produit laitier
BR112016025074A2 (pt) produto de espuma
DK3182958T4 (da) Aripiprazol-prodrugsammensætninger
EP3530120A4 (fr) Article de confiserie
FR3028721B3 (fr) Produit alimentaire
FR3019990B3 (fr) Produit medical